At the seventy-seventh national pharmaceutical Fair held recently, the listed pharmaceutical enterprises in Wenzhou were more concerned than ever. With a listed company this gold card, it is equivalent to the drug and standardized painting on the same sign. Since March 15th this year, Chengyi pharmaceutical industry knock a gong in Shanghai Stock Exchange , the power of capital for the year 50 enterprises once again full of vitality.

▌Adhere to innovation, More than 50 years of enterprise Glow vitality

This is Dongtou's first listed company, the Chengyi pharmaceutical industry Gong announced the listing surprised many people in Shanghai: Island Dongtou was born to know Wenzhou listed companies, several economic strength in Dongtou county (city, district) is still listed blank, and it's fresh in front of the public voice "in Wenzhou, visibility is also the general enterprise, was successfully listed.

In the light of the capital aura, more than two months time, the Chengyi pharmaceutical industry, financing, R & D and other aspects have made new progress. A total of 280 million yuan of net funds raised by the Chengyip harmaceutical industry will be invested in the technical renovation projects, marketing network construction projects and R & D center construction projects of the preparation building. Through the construction of investment projects to raise funds, will further expand the product market share, to further enhance the level of drug development and testing capabilities, strengthen and deepen marketing network layout in the country, lay a good foundation for the sustained and stable development.

Chengyi pharmaceutical began in 1960, founded in Copper Mt. pharmaceutical factory, along the way can not be separated from the persistence of innovation. Pharmaceutical innovation and transformation and upgrading is becoming the key word for the development of the pharmaceutical industry, and further expanding the proportion of preparations will become an important direction of the company's transformation and development. Over the past ten years, the pharmaceutical industry has been constantly changing, and gradually make big preparations. At present, the sales revenue of preparations has accounted for more than 50% of the company's sales, and it has been successfully transformed from raw materials to pharmaceutical preparations. It is understood that the pharmaceutical industry will increase the sincerity of new drug research and development, in the "13th Five-Year" period will invest at least 210 million yuan for the new drug development and technical innovation of production, R & D funds will reach above the average annual sales of 4%.

▍Capital power, marine medicine Set sail
The medicine before this, pure traditional Chinese medicine preparation new product bile Yining Chengyi pharmaceutical launched by the great attention of participating merchants. Sincerity pharmaceutical Dong Mike Ze Hui said: "this is the exclusive product of the country, the treatment of cholecystitis has a very significant effect.". The coming market will be the gospel of the overwhelming majority of people suffering from liver and gallbladder diseases."

With the help of capital, Chengyi pharmaceutical is locked on the target of marine medicine, bio pharmaceutical and other fields of medicine, tablet, granule, freeze-drying and other forms of extension and development at the same time in the development of new products, more emphasis on products. Of the 42 products newly developed, 33 belong to the preparation products, accounting for 78.57%.
"To operate a high-tech pharmaceutical enterprises, the key to focus on, the eyes should look forward, but also down-to-earth." Chengyi pharmaceutical chairman Yan Yiyi said that in the next 5 years, the company will deepen the transformation from raw materials to finished products at the same time, continue to advance towards the research and development of marine medicine, bio pharmaceutical and medicine direction, build the big health industry.

"To operate a high-tech pharmaceutical enterprises, the key to focus on, the eyes should look forward, but also down-to-earth." Chengyi pharmaceutical chairman Yan Yiyi said that in the next 5 years, the company will deepen the transformation from raw materials to finished products at the same time, continue to advance towards the research and development of marine medicine, bio pharmaceutical and medicine direction, build the big health industry.

The scale of the Chengyi pharmaceutical industry is not large, but the plant area is only 100 thousand square meters, and even the executive's office seems a bit crowded. In the interview, some employees smiled and told reporters: "our company is very willing to invest in technology, and office hardware always ranks second."." Such a careless words, reflects the helm of Yan Yiyi enterprises do attitude. The sustainable development of enterprises rely on the standard management, industrial upgrading is relying on R & D investment, experienced over the years the influence of Yiyi Yan injection can resist the essence of "Chengyi pharmaceutical market storm".

After the listing of the Chengyi pharmaceutical industry, there is a huge potential for development. According to the first quarter of 2017 reported that the company achieved operating income of 82 million 311 thousand yuan, an increase of 16.48%; net profit of 14 million 175 thousand and 200 yuan, an increase of 23.75%. The sincerity pharmaceutical industry is riding the listing Dongfeng, sails in the marine medicine domain journey!

▍Reporter notes: listen to the silent thunder
Witnessed the whole process of the development of the Chengyi pharmaceutical industry, its listing case is really worth learning. For the listing, the Chengyi pharmaceutical industry does not have the "natural" advantage. The Chengyi pharmaceutical industry is located in Dongtou, the geographical location is remote, the information source is also relatively blocked. In this environment, the Chengyi pharmaceutical industry, another way, eyeing the pharmaceutical. There are 50 years of history in the pharmaceutical industry, and many traditional enterprises in Wenzhou, the early years of technology and profits are not too high.

However, this difficulty does not become the enterprises listed on the "stumbling block", the success of the Chengyi pharmaceutical enterprises at the helm cannot do without the ambition and determination! Its success is inspiring. At present, some enterprises listed lack of passion, lack of market power, not listed, not listed, not listed "thinking, and sincerity pharmaceutical IPO success, is undoubtedly the" listen to the silent thunder". Listing and listing of enterprises is a systematic work, which requires the government, enterprises, intermediaries and other efforts, but the most critical is the transformation of the enterprise itself.